⏰Date & Time: Novembe 17th, 2026 at 5:30 PM (PST)  8:30 PM (EST)

💉Live Demonstration: Yes 

🎯Live Demo – Midface Volumization & Lip Rejuvenation

📢 We will cover:

✔ MACRO Core Technology & Usable HA Science: Understand the proprietary double-processing manufacturing method that creates a uniform 3D HA matrix. Learn the crucial clinical distinction between total HA (23 mg/mL) and usable cross-linked HA (17.5 mg/mL), and why measuring post-manufacturing cross-linked HA prevents unpredictable initial swelling and ensures stable long-term duration.

✔ Particle Size Uniformity & Consistent Extrusion: Compare MagIQ’s tight particle distribution (DV50 = 374 µm) against legacy particulate fillers. Discover how consistent particle sizing delivers a soft, uniform extrusion force through 27G and 30G needles, reducing tissue trauma and injector hand fatigue while enhancing precision.

✔ Clinical Rheology & "Goop on Bone" Tissue Integration: Master the G' (147 Pa) and stretchability profile of MagIQ™, placing it alongside versatile medium G' prime fillers like Restylane® Contour and Voluma/Vollure alternatives. Adopt a practical "jelly, not glue" mindset—learning how to place filler in proper tissue planes (subdermal to deep dermal) for natural tissue movement rather than over-relying on theoretical physics.

✔ Targeted Indications & Off-Label Injection Pearls: Explore primary indications for nasolabial folds, marionette lines, and perioral rhytides, along with advanced off-label techniques for midface cheek elevation and subtle lip volumization. Gain step-by-step insights from live demonstrations using retrograde, fanning, and structural strut techniques with gentle post-injection molding ("squishing") for seamless tissue integration.

✔ Safety Data, MAUDE Insights & Adverse Event Realities: Analyze pivotal U.S. clinical trial data (270 patients across Fitzpatrick skin types I–VI) demonstrating a 0.005% adverse event rate and non-inferiority to Juvéderm® Ultra® XC through 12 months. Review 12–15 years of European safety history under the saypha® brand name, examine MAUDE database findings on delayed-onset nodules, and differentiate true product safety from technique-driven complications like vascular occlusions.

✔ Standardized $200 Pricing & Outcome-Based Practice Growth: Overcome the frustration of tiered manufacturer purchasing tiers with Obagi’s flat $200/syringe cost structure. Learn how to re-educate patients on full correction for true 9–12 month longevity and transition your clinic from price-per-syringe sales to confident outcome-based pricing that protects profit margins and elevates patient satisfaction.

Whether you are looking to introduce Obagi® saypha MagIQ™ to your practice or refine your clinical techniques with next-generation HA fillers, this training is your guide to safer, more predictable, and business-savvy injectable outcomes.

Can’t make it live? 🎥 A recording will be available!

This includes continued online access to the webinar replay from your computer and/or mobile device for one year. If you have any questions or need assistance, please email us at: learn@theaestheticimmersion.com. 

By registering, you are giving permission to The Aesthetic Immersion to contact you via email and phone for future events and promotions.